251 related articles for article (PubMed ID: 30334858)
1. Clinical usefulness of 99mTc-HYNIC-TOC, 99mTc(V)-DMSA, and 99mTc-MIBI SPECT in the evaluation of pituitary adenomas.
Vukomanovic VR; Matovic M; Doknic M; Ignjatovic V; Simic Vukomanovic I; Djukic S; Peulic M; Djukic A
Nucl Med Commun; 2019 Jan; 40(1):41-51. PubMed ID: 30334858
[TBL] [Abstract][Full Text] [Related]
2. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
Colao A; Ferone D; Lombardi G; Lastoria S
Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m pentavalent dimercaptosuccinic acid imaging in patients with pituitary adenomas.
Lastoria S; Colao A; Vergara E; Ferone D; Varrella P; Merola B; Lombardi G; Salvatore M
Eur J Endocrinol; 1995 Jul; 133(1):38-47. PubMed ID: 7627336
[TBL] [Abstract][Full Text] [Related]
4. THE ROLE OF TUMOR-SEEKING RADIOPHARMACEUTICALS IN THE DIAGNOSIS AND MANAGEMENT OF ADRENAL TUMORS.
Vukomanovic V; Matovic M; Djukic A; Ignjatovic V; Vuleta K; Djukic S; Simic Vukomanovic I
Acta Endocrinol (Buchar); 2020; 16(3):316-323. PubMed ID: 33363653
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m sestamibi single photon emission computed tomography findings correlated with P-glycoprotein expression in pituitary adenoma.
Kunishio K; Okada M; Matsumoto Y; Nagao S; Nishiyama Y
J Med Invest; 2006 Aug; 53(3-4):285-91. PubMed ID: 16953066
[TBL] [Abstract][Full Text] [Related]
6. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of pituitary adenomas from other sellar and parasellar tumors by 99mTc(V)-DMSA scintigraphy.
Yamamura K; Suzuki S; Yamamoto I
Neurol Med Chir (Tokyo); 2003 Apr; 43(4):181-6; discussion 187. PubMed ID: 12760496
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
[TBL] [Abstract][Full Text] [Related]
9. Is technetium-99m-MIBI taken up by the normal pituitary gland? A comparison of normal pituitary glands and pituitary adenomas.
Kojima T; Mizumura S; Kumita SI; Kumazaki T; Teramoto A
Ann Nucl Med; 2001 Aug; 15(4):321-7. PubMed ID: 11577756
[TBL] [Abstract][Full Text] [Related]
10. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of Incidental Pituitary TC-99m MIBI Uptake on Parathyroid Spect and Factors Affecting Uptake Intensity.
Araz M; Cayir D; Ucan B; Dilli A; Çakal E
Cancer Biother Radiopharm; 2018 Sep; 33(7):295-299. PubMed ID: 29924654
[TBL] [Abstract][Full Text] [Related]
12. Initial direct comparison of 99mTc-TOC and 99mTc-TATE in identifying sites of disease in patients with proven GEP NETs.
Cwikla JB; Mikolajczak R; Pawlak D; Buscombe JR; Nasierowska-Guttmejer A; Bator A; Maecke HR; Walecki J
J Nucl Med; 2008 Jul; 49(7):1060-5. PubMed ID: 18552141
[TBL] [Abstract][Full Text] [Related]
13. A new semiquantitative method for comparing brain tumor uptake of Tc-99m sestamibi and TI-201.
San Pedro EC; Yilmaz M; Liu HG; Rosenfeld SS; Mountz JM
Clin Nucl Med; 1999 Nov; 24(11):868-73. PubMed ID: 10551470
[TBL] [Abstract][Full Text] [Related]
14. Incremental value of
Trogrlic M; Težak S
Nuklearmedizin; 2017 Jun; 56(3):97-107. PubMed ID: 28164207
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-3P4-RGD2 scintimammography in the assessment of breast lesions: comparative study with 99mTc-MIBI.
Ma Q; Chen B; Gao S; Ji T; Wen Q; Song Y; Zhu L; Xu Z; Liu L
PLoS One; 2014; 9(9):e108349. PubMed ID: 25250628
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors.
Trogrlic M; Tezak S
Nucl Med Rev Cent East Eur; 2016; 19(2):74-80. PubMed ID: 27479884
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of brain tumors by simultaneous dual isotope SPECT with 201Tl-chloride and 99mTc-MIBI].
Nagai H; Yamasaki T; Yamamoto Y; Takada D; Miyazaki T; Sugimoto K; Matsumoto Y; Akiyama Y; Moritake K
No Shinkei Geka; 2004 Oct; 32(10):1029-37. PubMed ID: 15529789
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific radiation dosimetry of 99mTc-HYNIC-Tyr3-octreotide in neuroendocrine tumors.
Grimes J; Celler A; Birkenfeld B; Shcherbinin S; Listewnik MH; Piwowarska-Bilska H; Mikolajczak R; Zorga P
J Nucl Med; 2011 Sep; 52(9):1474-81. PubMed ID: 21795364
[TBL] [Abstract][Full Text] [Related]
20.
Beheshti M; Hehenwarter L; Paymani Z; Rendl G; Imamovic L; Rettenbacher R; Tsybrovskyy O; Langsteger W; Pirich C
Eur J Nucl Med Mol Imaging; 2018 Sep; 45(10):1762-1771. PubMed ID: 29516131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
